Stockholders’ Equity - Recent Equity Financings Narrative (Details) - USD ($) $ / shares in Units, $ in Millions				12 Months Ended
	Dec. 19, 2025	Nov. 10, 2025	Sep. 11, 2025	Dec. 31, 2025	Dec. 31, 2024	Dec. 18, 2025
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock, commission rate to sales agents				3.00%
Private Placement
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock (in shares)			26,717,414
Proceeds from sale of common stock and warrants			$ 50.1
Payments of stock and warrant issuance costs			$ 3.3
Registration statement filing requirement period			30 days
Registration statement filing period			75 days
Private Placement | Prefunded Warrants, Liability
Convertible Preferred Stock and Stockholders' Deficit
Pre-funded warrants issued (in shares)			6,003,758
Sale of stock, price per warrant (in USD per share)			$ 1.5299
Exercise price of warrants (in USD per share)			$ 0.0001
Sale of stock, specified beneficial ownership threshold maximum			19.99%
Private Placement | Management
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock (in shares)			36,361
Sale of stock (in USD per share)			$ 1.65
Shelf Registration Statement
Convertible Preferred Stock and Stockholders' Deficit
Stock issued		$ 300.0
At-The-Market Sales Agreement
Convertible Preferred Stock and Stockholders' Deficit
Stock issued				$ 100.0
Third Party Investor | Private Placement
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock (in shares)			26,681,053
Sale of stock (in USD per share)			$ 1.53
Leerink Partners LLC | Underwritten Offering
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock (in USD per share)						$ 6.00
Issuance of common stock (in shares)	5,000,000
Gross proceeds	$ 30.0
Common stock
Convertible Preferred Stock and Stockholders' Deficit
Issuance of common stock (in shares)				31,717,415	7,463,762